-
Specialized in protecting the bladder: precise radiofrequency resection of bladder tumors and techniques
Time of Update: 2022-03-09
Research and development of plasma needle ring electrodes and bladder tumor removal baskets to provide a total solution for transurethral resection of bladder tumors; 4.
Creation of super transurethral resection of bladder tumor (STURBT), and report at the AUA annual meeting; 7.
-
Interpretation by Dr Neil Skolnik from an International Perspective: The Latest AUA Guidelines - Management of BPH/LUTS
Time of Update: 2022-03-09
Neil Skolnik interprets the latest AUA guideline on the management of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) .
For men with severe symptoms of urinary retention (urgency and frequency), anticholinergic drugs, such as tolterodine or oxybutynin, can be used alone or in combination with alpha-blockers .
-
Second-generation hormone therapy prolongs survival in patients with locally advanced prostate cancer
Time of Update: 2022-03-09
For metastatic prostate cancer, there is convincing evidence from phase 3 trials that intensification of ADT with docetaxel or second-generation hormone therapy (abiraterone, enzalutamide, and apalutamide) is associated with overall survival Benefit; limited data for high-risk locally advanced prostate cancer .
-
Table 7 Summary: Diagnosis and Treatment of Patients with Premature Ejaculation
Time of Update: 2022-03-08
Psychological counseling and sexual health education Psychological counseling should run through the diagnosis and treatment of PE, through psychological counseling or effective communication with patients and sexual partners to understand the potential causes of PE, so as to formulate a comprehensive treatment plan combining psychology, skill counseling and drugs .
-
"Ancient Early" research has been featured in the JAMA sub-journal after 20 years because...
Time of Update: 2022-03-08
Recently, a cohort study investigating the optimal duration of androgen deprivation therapy after radiotherapy in high-risk prostate cancer patients was published in JAMA Oncology .
-
Molecular Therapy Fudan University Jiang Haowen Reveals the Potential Mechanism of Exosomal CircRNA Regulating the Malignant Phenotype of Bladder Cancer
Time of Update: 2022-03-08
On January 12, 2022, Fudan University Jiang Haowen's team published an online article entitled "Exosome derived circTRPS1 promotes malignant phenotype and CD8+ Tcell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration in Molecular Therapy (IF=11).
-
Elderly patients: how to treat recurrent prostate cancer recurrence in renal failure?
Time of Update: 2022-03-08
Imaging findings on a 68Ga PSMA-11 PET scan suggest recurrence of prostate cancer with lymph node involvement in the left supraclavicular, mediastinum, retropedicular, para-aortic and aortic, pelvic, and inguinal regions (Figure 1) .
-
Daily care of catheter, nephrostomy, cystostomy, learn quickly!
Time of Update: 2022-03-08
In this issue of "Manage Tumors", we invite Chen Yiwen, the head nurse of the Medical Oncology Department of Zhongshan Hospital Affiliated to Fudan University, to talk with us about the daily care of urinary catheters, nephrostomy, and cystostomy .
-
[From study08 to PROpel] Olapali mCRPC's road to the front line of the whole crowd
Time of Update: 2022-03-08
Study08 showed that the combination therapy brought significant clinical benefit to mCRPC patients (regardless of HRR mutation status), and the overall safety was good .
-
Prof. He Zhisong: Important Clinical Research on Urological Tumors in 2021
Time of Update: 2022-02-24
Subgroup analysis based on the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk score shows progression-free survival (PFS) of pembrolizumab combined with axitinib in the low-risk group compared with sunitinib No significant benefit was achieved, but the intermediate and high risk group benefited; the low-risk group also did not achieve significant OS benefit, with 42-month OS rates of 72.
-
A new strategy for epigenetic therapy of prostate cancer based on targeting SWI/SNF chromatin remodeling complex ATPase
Time of Update: 2022-02-24
Chinnaiyan at the Michigan Center for Translational Pathology (MCTP) at the University of Michigan School of Medicine published in Nature a report titled Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer research paper .
-
BMJ sub-journal: Chinese scholars find that drinking more coffee reduces the risk of prostate cancer in men
Time of Update: 2022-02-24
To investigate the association between coffee intake and prostate cancer risk, the research team searched databases of relevant cohort studies published up to September 2020 .
Overall, this study suggests that increased coffee consumption may be associated with a lower risk of prostate cancer .
-
An article to explore: Lynch syndrome and the third most related tumor UTUC those things
Time of Update: 2022-02-24
Abstract Upper urothelial carcinoma (UTUC) is the third most common malignancy associated with Lynch syndrome (LS) Related literatures such as screening programs and screening protocols were analyzed and expected to provide urologists with more detailed information on LS and UTUC .
-
An annoying urinary tract infection, how to deal with it?
Time of Update: 2022-02-24
Causes Urinary tract infections usually occur when bacteria pass through the urethra into the urinary tract and begin to multiply in the bladder .
The most common urinary tract infection seen in women: Bladder infection (cystitis): Usually caused by E.
-
Gao Fei/Li Zheng et al. Reveal the causative gene of male azoospermia and repair it by CRISPR gene editing
Time of Update: 2022-02-24
This study revealed that MSH5 gene mutation is a potential cause of non-obstructive azoospermia (NOA), and confirmed in a mouse model that CRISPR/Cas9 gene editing can repair the gene mutation and produce mature sperm .
-
After the tumor was removed, the patient regretted it?
Time of Update: 2022-02-24
Professor Zhu Yao: In order to avoid regret after treatment to the greatest extent, clinicians need to fully communicate with patients before treatment .
Therefore, clinicians need to fully understand the patient's treatment expectations and communicate with them about the possible side effects of treatment .
-
Latest expert consensus: 7 clinical recommendations for testosterone management
Time of Update: 2022-02-24
Androgen deprivation therapy (ADT) is one of the most important basic treatments for prostate cancer, and its main goal is to reduce serum testosterone and maintain it below castration levels .
-
The efficacy of immunotherapy lasts for more than 2 years, and the expression level of PD-L1 after chemotherapy may predict the efficacy of bladder cancer practice cases
Time of Update: 2022-02-24
This case reports a patient with locally advanced T4 bladder cancer who achieved a complete response (CR) with pembrolizumab after progression on chemotherapy and radiotherapy .
Conclusions In this case report, a patient with stage T4 locally invasive bladder cancer achieved CR with pembrolizumab after progression on chemoradiotherapy .
-
Novel endocrine drugs: first-line treatment of CRPC
Time of Update: 2022-02-24
Table 1 Efficacy and safety of enzalutamide and abiraterone in patients with CRPC in the treatment of metastatic castration-resistant prostate cancer In the PREVAIL study [8], the Japanese/Asian subgroup was basically the same as the overall population .
-
Learn the etiology, diagnosis and treatment of epididymitis in one article!
Time of Update: 2022-02-24
Introduction The epididymis is a reproductive organ located at the back of the testis and connected to the vas deferens . The epididymis can store and carry sperm . After the sperm leaves the t
